Showing results (91-100 of 135) with videos related to
Sort By:
Pageof 14
AJR. American Journal of Roentgenology|August 1, 1997
CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteriaS Hilton, H W Herr, J B Teitcher, et al.American Journal of Epidemiology|September 15, 1995
Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the Surveillance, Epidemiology, and End Results (SEER) programC B Begg, Z F Zhang, M Sun, et al.Cancer Research|January 1, 1982
Surface marker identification of small cleaved follicular center cell lymphomas with a highly favorable prognosisR A Rudders, E T Ahl, R A Delellis, et al.Cancer|December 15, 1983
Adult non-Hodgkin's lymphoma. Correlation of cell surface marker phenotype with prognosis, the new working formulation, and the Rappaport and Lukes-Collins histomorphologic schemesR A Rudders, R A DeLellis, E T Ahl, et al.Ultrasound in Medicine & Biology|January 1, 1996
ROC analysis of noninvasive tests for peripheral arterial diseaseJ G Lijmer, M G Hunink, J J van den Dungen, et al.Journal of Vascular Surgery|October 24, 1998
Cost-identification analysis of revascularization procedures on patients with peripheral arterial occlusive diseaseR M Jansen, S O de Vries, K A Cullen, et al.Cancer Treatment Reports|January 1, 1980
Randomized clinical trial comparing two dose regimens of ICRF-159 in refractory malignant lymphomasM J O'Connell, C B Begg, M N Silverstein, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1984
A critical comparison of allogeneic bone marrow transplantation and conventional chemotherapy as treatment for acute nonlymphocytic leukemiaC B Begg, P B McGlave, J M Bennett, et al.Urology|April 1, 1997
Planning controlled clinical trials. Prostatic cancerL Denis, B J Norlén, L Holmberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
High-dose ifosfamide with mesna uroprotection: a phase I studyA D Elias, J P Eder, T Shea, et al.Pageof 14